Status:
COMPLETED
Natural History in CCFDN and IBM Syndromes
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Inclusion Body Myositis, Sporadic
Inclusion Body Myopathy, Autosomal-recessive
Eligibility:
All Genders
Brief Summary
So far, only limited data is available regarding the natural course in Congenital Cataract Facial Dysmorphism Neuropathy Syndrome (CCFDN) and sporadic and hereditary inclusion body myopathies (IBM). S...
Detailed Description
We wanted to assess the natural course in Congenital Cataract Facial Dysmorphism Neuropathy Syndrome (CCFDN) and sporadic and hereditary inclusion body myopathies (IBM) over 10 years to gain new insig...
Eligibility Criteria
Inclusion
- Clinical and/or genetic diagnosis of Congenital Cataract Facial Dysmorphism Neuropathy Syndrome (CCFDN) and sporadic and hereditary inclusion body myopathies (IBM)
Exclusion
- Additional neuromuscular diseases
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT01902940
Start Date
June 1 2013
End Date
October 1 2013
Last Update
September 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friedrich-Baur-Institut, Ludwig-Maximilians-University of Munich
Munich, Bavaria, Germany, 80336